Table 3:
Prevalence of day 3 parasitaemia and Pfkelch13 R561H mutation in pre-treatment isolates in the three study sites
| Day 3 parasitaemia positive |
Day 3 parasitaemia negative |
|||
|---|---|---|---|---|
| 561H mutation | R561 wildtype | 561H mutation | R561 wildtype | |
|
| ||||
| Rukara (n=82) | 5 (6·1%) | 7 (8·5%) | 13 (15·9%) | 57 (69·5%) |
| Masaka (n=51) | 6 (11·8%) | 2 (3·9%) | 4 (7·8%) | 39 (76·5%) |
| Bugarama (n=85) | 0 (0·0%) | 0 (0·0%) | 0 (0·0%) | 85 (100%) |
Data are n (%). Pfkelch13=Plasmodium falciparum kelch 13.